Overview
An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-1)
Status:
Recruiting
Recruiting
Trial end date:
2021-12-14
2021-12-14
Target enrollment:
0
0
Participant gender:
All
All
Summary
This is a 4-visit, multi-center, randomized, double-masked, vehicle-controlled study evaluating the safety and efficacy of CSF-1 in the temporary correction of presbyopia.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Orasis Pharmaceuticals Ltd.
Criteria
Inclusion Criteria:- Subjects must have presbyopia.
Exclusion Criteria:
Subjects must not:
- Have any contraindications to the study medications or diagnoses that would confound
the study.